Tech Transfer At Risk: The Imperative For Digital Maturity And Modernization

Technology transfer (tech transfer) is a critical process in biopharmaceutical manufacturing, enabling the seamless transition of drug production processes from development to commercialization. This intricate process is no longer a luxury, but a necessity. The rise of complex therapies and global competition demands streamlined processes to accelerate manufacturing and reduce time to market.

This white paper explores the critical role of technology transfer in ensuring the seamless and accurate reproduction of high-quality therapeutics. We delve into the challenges inherent in tech transfer, including the complexities of transferring intricate processes, managing ambiguities, and maintaining regulatory compliance. Crucially, we examine how digital maturity and the strategic implementation of digital tools can revolutionize tech transfer, enabling efficient knowledge transfer, data-driven decision-making, and ultimately, faster delivery of life-changing therapies to patients.